Results 11 to 20 of about 46,868 (196)
Stroke in pediatric ventricular assist device support [PDF]
Stroke continues to be one of the most significant hemocompatibility related adverse event in pediatric ventricular assist device support. Tremendous gains have been made in reducing the incidence of stroke across all ages, diagnoses and device types ...
Christina VanderPluym, MD +2 more
doaj +2 more sources
Recent Developments in Ventricular Assist Device Therapy [PDF]
The evolution of left ventricular assist devices (LVADs) from large, pulsatile systems to compact, continuous-flow pumps has significantly improved implantation outcomes and patient mobility. Minimally invasive surgical techniques have emerged that offer
Angel Moctezuma-Ramirez +3 more
doaj +2 more sources
Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center [PDF]
Background/Aims The continuous flow left ventricular assist device (cf-LVAD) has improved the survival of chronic end-stage heart failure (HF) patients.
Yoonjee Park +5 more
doaj +1 more source
Echocardiography in left ventricular assist device
Sherif M Helmy +2 more
doaj +2 more sources
Background: Recent studies describe an emerging role for percutaneous left ventricular assist devices such as Impella CP® as rescue therapy for refractory cardiac arrest.
Adam L. Gottula +9 more
doaj +1 more source
Background: Patients with a left ventricular assist device with right ventricular failure are prioritized on the heart transplant waitlist; however, their post-transplant survival is less well characterized.
Yaron D. Barac, MD, PhD +7 more
doaj +1 more source
Pediatric Ventricular Assist Device [PDF]
There have been great advances in ventricular assist device (VAD) treatment for pediatric patients with advanced heart failure. VAD support provides more time for the patient in the heart transplant waiting list. Augmented cardiac output improves heart failure symptoms, end-organ function, and general condition, and consequently provides beneficial ...
Yu Rim Shin +2 more
openaire +3 more sources
Despite major advances in the treatment of heart failure over the past two decades, improving the natural history of this condition, heart failure continues to be a major source of morbidity and mortality. Although availability of heart donor for transplantation has declined over the past several years, innovations in ventricular assist device (VAD ...
TARANTINI, GIUSEPPE +7 more
openaire +6 more sources
Background Extracorporeal left ventricular assist device is often required for acute myocardial infarction patients in cardiogenic shock when temporary mechanical circulatory support fails to provide hemodynamic stabilization.
Chiho Tokunaga +8 more
doaj +1 more source
Implantable left ventricular assist device (LVAD) is a state-of-the-art treatment for adults and children with end-stage heart failure. The early and late period after LVAD implantation can be severely complicated.
V. N. Poptsov +4 more
doaj +1 more source

